Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)
key details
| Value | £16,295,088 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 1 Nov 2020 |
| Contract start | 1 Dec 2020 |
| Contract end | 1 Dec 2020 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-d83c0d3f-efcc-4d08-aa7c-b86364abc312 |
Awards (15)
This procurement was awarded to 15 suppliers. Values shown are per-award; the notice total is £16,295,088.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £16,295,088 | 11 Nov 2020 | active |
| Aguettant Ltd shared | £16,295,088 | 11 Nov 2020 | active |
| Aspen Pharma Ireland Limited shared | £16,295,088 | 11 Nov 2020 | active |
| Aventis Pharma ltd t/a Sanofi shared | £16,295,088 | 11 Nov 2020 | active |
| B. Braun Medical Limited shared | £16,295,088 | 11 Nov 2020 | active |
| BioQ Pharma B.V., a subsidiary of BioQ Pharma Incorporated shared | £16,295,088 | 11 Nov 2020 | active |
| CST Pharma Limited shared | £16,295,088 | 11 Nov 2020 | active |
| Fresenius Kabi Limited shared | £16,295,088 | 11 Nov 2020 | active |
| hameln pharma ltd shared | £16,295,088 | 11 Nov 2020 | active |
| Kent Pharma Ltd shared | £16,295,088 | 11 Nov 2020 | active |
| Martindale Pharma shared | £16,295,088 | 11 Nov 2020 | active |
| Neon Healthcare Ltd shared | £16,295,088 | 11 Nov 2020 | active |
| Piramal Critical care Limited shared | £16,295,088 | 11 Nov 2020 | active |
| Torbay Pharmaceuticals shared | £16,295,088 | 11 Nov 2020 | active |
| Wockhardt UK Limited shared | £16,295,088 | 11 Nov 2020 | active |
description
A procurement exercise for supportive medicines that includes End of Life, Intensive Treatment Unit and Antibiotics medicines.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 25 Nov 2020 | Planning (planning) | · | 64b0e85a-78d4-4edc-ae7d-eba6df3b081b-395925 |
| 30 Apr 2021 | Award update (awardUpdate) | · | 45f18750-911c-41e9-9659-2a3f76c83cc5-433038 |
more from Department of Health and Social Care (DHSC)
- Hugh's Report-MH Impact of Life-threatening Child Illness on families 2026 · £216,540 · 26 Jun 2026
- D&B + API Interface · £542,011 · 25 Jun 2026
- NCMP IT System - Discovery Phase · £183,768 · 19 May 2026
- DHSC: CL Temporary Executive Support to the Permanent Secretary - JW · £17,702 · 19 May 2026
- DHSC: GO: 26/27 - WIST: DAC hosting on CSP · £168,000 · 2 Apr 2026
- RM1043.8-1-DEPARTMENT OF HEALTH AND SOCIAL CARE - Find Public Health Data · £1,251,360 · 2 Apr 2026
- DHSC:NHST: National GP Engagement on Health Data · £267,000 · 31 Mar 2026
- DHSC: CL FGO Contingent Labour SD Extension · £133,710 · 31 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.